Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2020-02-21 19:08:44
Bergen, Norway, 21 February 2020 - The Board of Directors in BerGenBio ASA (the "Company") (OSE: BGBIO) approved the 2019 annual financial statements prepared in accordance with International Financial Reporting Standards (IFRS). The statements are in accordance with the preliminary 2019 annual financial statements published on 11 February 2020. The annual report 2019 will be made available on BerGenBio ASA's web site www.bergenbio.com on 24 February 2020. BerGenBio ASA's annual general meeting is planned to be held on 16 March 2020. -End- Contacts Richard Godfrey CEO, BerGenBio ASA +47 917 86 304 Rune Skeie CFO, BerGenBio ASA rune.skeie@bergenbio.com +47 917 86 513 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.